This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Neurology  • Alert me on articles by topic

Tracy Hampton, PhD

JAMA. 2004;291:810.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The Food and Drug Administration (FDA) continues to implement more stringent regulations to thwart the potential spread of bovine spongiform encephalopathy (BSE, or "mad cow" disease) in the United States after the discovery of an infected Holstein in December. The agency has now imposed several bans that will affect human food, including dietary supplements, and cosmetics.

Material from "downer" cattle (animals too sick or injured to stand) or cattle that die before slaughter will be banned, along with other bovine-derived material, including risk materials from any cows 30 months or older (such as brain, skull, eyes, and spinal cord), as well as a portion of the small intestine and tonsils from all cattle.

Certain feeding practices have also been prohibited to help eliminate potential sources of BSE. Mammalian blood and blood products, "poultry litter" (bedding, spilled feed, feathers, and fecal matter from chicken coops), and "plate waste" . . . [Full Text of this Article]